These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1576 related articles for article (PubMed ID: 9596994)
21. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC; Lin-Shiau SY; Chen CF; Lin JK J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699 [TBL] [Abstract][Full Text] [Related]
22. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912 [TBL] [Abstract][Full Text] [Related]
23. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461 [TBL] [Abstract][Full Text] [Related]
24. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Phelps DE; Xiong Y Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177 [TBL] [Abstract][Full Text] [Related]
25. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686 [TBL] [Abstract][Full Text] [Related]
26. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430 [TBL] [Abstract][Full Text] [Related]
27. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197 [TBL] [Abstract][Full Text] [Related]
28. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts. Kilbey A; Stephens V; Bartholomew C Cell Growth Differ; 1999 Sep; 10(9):601-10. PubMed ID: 10511310 [TBL] [Abstract][Full Text] [Related]
29. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087 [TBL] [Abstract][Full Text] [Related]
30. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049 [TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells. Ehmann GL; McLean TI; Bachenheimer SL Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629 [TBL] [Abstract][Full Text] [Related]
32. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). Wang G; Miskimins R; Miskimins WK Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466 [TBL] [Abstract][Full Text] [Related]
33. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Dietrich C; Wallenfang K; Oesch F; Wieser R Oncogene; 1997 Nov; 15(22):2743-7. PubMed ID: 9401001 [TBL] [Abstract][Full Text] [Related]
34. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells. Mann DJ; Higgins T; Jones NC; Rozengurt E Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381 [TBL] [Abstract][Full Text] [Related]
35. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2. Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts. Ravitz MJ; Yan S; Herr KD; Wenner CE Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344 [TBL] [Abstract][Full Text] [Related]
37. Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells. Wang QM; Feinman R; Kashanchi F; Houghton JM; Studzinski GP; Harrison LE Clin Cancer Res; 2000 Jul; 6(7):2951-8. PubMed ID: 10914745 [TBL] [Abstract][Full Text] [Related]
38. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest. Srethapakdi M; Liu F; Tavorath R; Rosen N Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672 [TBL] [Abstract][Full Text] [Related]
40. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest. Loubat A; Rochet N; Turchi L; Rezzonico R; Far DF; Auberger P; Rossi B; Ponzio G Oncogene; 1999 Jun; 18(22):3324-33. PubMed ID: 10362353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]